510(k) Report

510(k) · Cleared

Cleared

HERA Interlocking Intramedullary Nailing System

K253046510(k) TraditionalCleared Jun 16, 2026267-day reviewClass II21 CFR 888.3020

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

ZheJiang Decans Medical Devices Co., Ltd. · HSB Rod, Fixation, Intramedullary And Accessories

Cleared on Jun 16, 2026 as substantially equivalent to K172830 (Double Medical Technology, Inc., 2018) and 3 other predicates after a 267-day review. Its family tree reaches back 5 generations to 1995.

Decided
Jun 16, 2026
Review
267 days
Class
Class II
Product code
HSB
Recalls
None
Predicates
4

Its longest line of descent runs back 5 generations to K951740 (1995). 24 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2014: 1 other ancestor2004: 5 other ancestors2005: 1 other ancestor2001: 3 other ancestors1999: 2 other ancestors1998: 4 other ancestors2003: 1 other ancestor2002: 1 other ancestor2000: 1 other ancestorK951740 · Intramedulary Fixation Rod · Acu Med, Inc. · 1995 · recalledK032722 · Trigen Straight Humeral Nail System · Smith & Nephew, Inc. · 2003K051557 · Trigen Retrograde Femoral, Supracondylar and Tibial Nails · Smith & Nephew, Inc. · 2005K070761 · Sanatmetal Nails and Pins · Sanatmetal Mfr. of Orthopaedic/Traumatologic Prod. · 2008K172830 · Double Medical Femoral Nail System · Double Medical Technology, Inc. · 20181995200020052010201520202025
  1. Root · 5 generations backK951740 Intramedulary Fixation RodAcu Med, Inc. · 1995 · Recalled
  2. 4 generations backK032722 Trigen Straight Humeral Nail SystemSmith & Nephew, Inc. · 2003
  3. 3 generations backK051557 Trigen Retrograde Femoral, Supracondylar and Tibial NailsSmith & Nephew, Inc. · 2005
  4. 2 generations backK070761 Sanatmetal Nails and PinsSanatmetal Mfr. of Orthopaedic/Traumatologic Prod. · 2008
  5. 1 generation backK172830 Double Medical Femoral Nail SystemDouble Medical Technology, Inc. · 2018
  6. This deviceK253046 HERA Interlocking Intramedullary Nailing SystemZheJiang Decans Medical Devices Co., Ltd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K951740Intramedulary Fixation RodAcu Med, Inc.19951
−4K032722Trigen Straight Humeral Nail SystemSmith & Nephew, Inc.2003—
−3K051557Trigen Retrograde Femoral, Supracondylar and Tibial NailsSmith & Nephew, Inc.2005—
−2K070761Sanatmetal Nails and PinsSanatmetal Mfr. of Orthopaedic/Traumatologic Prod.2008—
−1K172830Double Medical Femoral Nail SystemDouble Medical Technology, Inc.2018—
0 (this device)K253046HERA Interlocking Intramedullary Nailing SystemZheJiang Decans Medical Devices Co., Ltd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199840
199920
200010
200130
200210
200310
200450
200510
201410
FIG. 1 — Lineage of K253046, 1995–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HSB? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HSB device

  1. #1 K200869 Gamma3 Systemscore 19.8 · 8 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K172830Double Medical Femoral Nail System
Summary page 5
…Double Medical Technology Inc. Trade name Double Medical Femoral Nail System 510(k) K172830 Primary Predicate Regulatory Class II Device Regulation Number 21CFR 888.3020, 21CFR888.3040…
Double Medical Technology, Inc.2018—
*K040212Trigen Intertan
Summary page 5
…Manufacturer Smith & Nephew, Inc. Trade name TriGen InterTAN 510(k) K040212 Additional Predicate Regulatory Class II Device Regulation Number 21CFR 888.3030…
Smith & Nephew, Inc.20046
*K040462Trigen Trochanteric Antegrade Nail
Summary page 5
…cturer Smith & Nephew, Inc. Trade name TriGen Trochanteric Antegrade Nail 510(k) K040462 Additional Predicate Regulatory Class II Device Regulation Number 21…
Smith & Nephew, Inc.20042
*K131609Double Engine Intrameddullary Nail System
Summary page 6
…K253046 - Page 2 of 3 510(k) K131609 Regulatory Class II Regulation Number 21CFR 888.3020…
Xiamen Double Engine Medical Material Co., Ltd.2014—

Also cleared against K172830: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 5 companies; a new generation was cleared every 7.8 years on median.
  • 11 of the 24 ancestors have a recall of any class.
  • 1 other device also cites its predicate K172830.

How does its category compare?

All HSB devices

HSB Rod, Fixation, Intramedullary And Accessories: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · HSB

15in 2025

2007: 82008: 112009: 182010: 142011: 162012: 172013: 182014: 192015: 222016: 82017: 232018: 172019: 132020: 172021: 102022: 122023: 112024: 132025: 152026 (partial year): 18
2007high 23 (2017) · low 8 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HSB

106in 2025

2007: 68 days median2008: 57 days median2009: 86 days median2010: 117 days median2011: 78 days median2012: 112 days median2013: 105 days median2014: 147 days median2015: 111 days median2016: 124 days median2017: 119 days median2018: 134 days median2019: 132 days median2020: 112 days median2021: 94 days median2022: 172 days median2023: 162 days median2024: 195 days median2025: 106 days median2026 (partial year): 151 days median
2007high 195 (2024) · low 57 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HSB

18in 2025

2008: 92009: 812010: 182011: 22012: 72013: 142014: 32015: 32016: 62017: 662018: 562019: 62020: 62021: 22022: 12023: 12024: 12025: 182026 (partial year): 1
2007high 81 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HSB

2,911in 2025

2007: 1622008: 1842009: 3342010: 4542011: 6622012: 1,0792013: 1,7732014: 1,4742015: 1,6712016: 1,9202017: 1,4472018: 3,5262019: 2,5172020: 3,2992021: 4,1112022: 2,7332023: 2,2192024: 2,8692025: 2,911
2007high 4,111 (2021) · low 162 (2007)2025

MAUDE reports naming product code HSB, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078680162
200811579184
2009188681334
20101411718454
201116782662
20121711271,079
201318105141,773
20141914731,474
20152211131,671
2016812461,920
201723119661,447
201817134563,526
20191313262,517
20201711263,299
2021109424,111
20221217212,733
20231116212,219
20241319512,869
202515106182,911
2026181511—

What is it indicated for?

(1)Femoral Trochanteric Fixation Nail System Femoral Trochanteric Fixation Nail System is intended use to: a)Pertrochanteric, intertrochanteric or Subtrochanteric fractures; b)Combination fractures of femur; c)Pathological fractures or reconstruction following tumor resection and grafting; d)Poor healing of fracture, including nonunions, malunions and bone lengthening or shortening; e)Other fracture, including simple severely comminuted, spiral, long…

Read the full statement (117 words)

(1)Femoral Trochanteric Fixation Nail System

Femoral Trochanteric Fixation Nail System is intended use to:

a)Pertrochanteric, intertrochanteric or Subtrochanteric fractures;

b)Combination fractures of femur;

c)Pathological fractures or reconstruction following tumor resection and grafting;

d)Poor healing of fracture, including nonunions, malunions and bone lengthening or shortening;

e)Other fracture, including simple severely comminuted, spiral, long oblique and segmental fractures of femur.

(2)Antegrade Femoral Reconstruction Nail System

Antegrade Femoral Reconstruction Nail System rencon mode is intended use to Femoral shaft and neck fracture ; standard mode is intended use to Femoral shaft fracture.

(3)Tibial Nail system

Tibial nail system is intended to be implanted into the medullary canal of tibia for alignment, stabilization, fixation of fractures caused by trauma or disease.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K253046: HERA Interlocking Intramedullary Nailing System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K253046

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026